Test Price
2,800 AED✅ Home Collection Available
UGT1A1 Gene Hyperbilirubinemia (Familial Transient Neonatal) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
DHA-Aligned Precision Diagnostics
99.9% Diagnostic Sensitivity via ISO 15189:2022 Accredited Next-Generation Sequencing (NGS) processing. Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. Clinical Guidance: Post-test genetic counseling session included with report delivery. Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This once-in-a-lifetime NGS test decodes the UGT1A1 gene to identify inherited variants causing severe neonatal jaundice and impaired bilirubin metabolism, enabling life-saving early interventions. The assay covers the full coding region, promoter, and intron-exon boundaries for single nucleotide variants (SNVs), insertions, and deletions.
| Feature | Our Test (DHA-Compliant) | Closest Alternative |
|---|---|---|
| Analytical Method | NGS + CNV Analysis | Sanger Sequencing or targeted panel |
| Turnaround Time | 10-14 Business Days (ISO Fast Track) | 4-6 Weeks |
| Coverage | Full gene, promoter, SNVs, indels | Limited to known hotspots |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I guide families that this NGS test precisely maps the molecular root of familial transient hyperbilirubinemia. However, the result must always be weighed against the infant's clinical trajectory and bilirubin dynamics. A negative screen does not exclude all causes of neonatal jaundice, and a positive result directs targeted surveillance but does not replace immediate medical assessment."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisory & Medication Guidance
Important: This test is diagnostic only. Do not alter or cease prescribed phototherapy, phenobarbital, or any other treatment without consulting your physician. The genetic result informs long-term management, while acute jaundice requires immediate clinical intervention.
Patient Exclusion & Emergency Red Flags
- Emergency Contraindication: Infant showing signs of acute bilirubin encephalopathy (lethargy, poor feeding, high-pitched cry) — seek emergency care immediately.
- Recent Transfusion: Blood transfusion within the last 2 weeks may compromise DNA analysis accuracy.
- Sample Volume: Inability to provide adequate sample volume (heel-prick card or whole blood) may delay processing.
🚨 Immediate ER Referral Required If:
- Jaundice appears within the first 24 hours of life.
- Total serum bilirubin rises >0.5 mg/dL per hour.
- Signs of kernicterus present: arching of back, seizures, apnea.
Patient FAQ & Clinical Guidance
1. What does the UGT1A1 NGS test actually detect?
Answer: This test identifies DNA variants in the entire UGT1A1 gene and its regulatory promoter that cause reduced enzyme activity, leading to severe neonatal jaundice. It provides a definitive molecular diagnosis for familial transient hyperbilirubinemia.
2. How is the sample collected for a newborn?
Answer: A small heel-prick blood drop on an FTA card or a gentle venous draw is sufficient. Our VIP Mobile Phlebotomy service dispatches a trained pediatric specialist to your home for stress-free collection.
3. Will my insurance cover the AED 2,800 cost?
Answer: We verify coverage instantly via WhatsApp; most UAE health plans reimburse this medically necessary genetic test when accompanied by a physician's request. Direct billing is available for approved insurers.
UAE Regulatory & Data Privacy Adherence
This facility strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical safety protocols and patient consent procedures are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | UGT1A1 Gene Hyperbilirubinemia (Familial Transient Neonatal) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 10-14 Business Days (ISO Fast Track) |
| Sample Type / Matrix | Peripheral Whole Blood, Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) + CNV Analysis |
| ICD-10-CM Code | E80.4 |
| LOINC Code | 21748-8 |
| DHA Facility License & Lab Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians